Optimal needle size for thyroid fine needle aspiration cytology.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Feb 2019
Historique:
pubmed: 23 11 2018
medline: 18 6 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

Concerning the needle size for thyroid fine needle aspiration cytology (FNAC), 25-27-gauge needles are generally used in Western countries. However, in Japan, the use of larger needles (21-22-gauge needles) is common. The aim of our study was to determine the optimal needle size for thyroid FNAC. We performed ultrasound-guided FNAC for 200 thyroid nodules in 200 patients using two different-sized needles (22 and 25 gauge). For each nodule, two passes with the different-sized needles were performed. The order of needle sizes was reversed for the second group of 100 nodules. The second aspiration was more painful than the first, regardless of the needle size. An association with more severe blood contamination was more frequently observed with the use of 22-gauge needles (32.0%) than with the use of 25-gauge needles (17.5%) and in the second aspiration (37.5%) than in the initial aspiration (12.0%). The initial aspiration samples were more cellular than the second aspiration samples. Regarding the unsatisfactory and malignancy detection rates, there was no statistical difference between the needles. In three of seven markedly calcified nodules, it was difficult to insert 25-gauge needles into the nodules. In terms of the diagnostic accuracy and pain, either needle size can be used. We recommend using 22-gauge needles for markedly calcified nodules because 25-gauge needles bend more easily in such cases. We demonstrated that the initial aspiration tended to obtain more cellular samples and to be less contaminated. Thus, the initial aspiration is more important and should be closely attended.

Identifiants

pubmed: 30464152
doi: 10.1507/endocrj.EJ18-0422
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-147

Auteurs

Aki Tanaka (A)

Department of Clinical Laboratory, Kuma Hospital, Kobe, Japan.

Mitsuyoshi Hirokawa (M)

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.

Miyoko Higuchi (M)

Department of Clinical Laboratory, Kuma Hospital, Kobe, Japan.

Risa Kanematsu (R)

Department of Clinical Laboratory, Kuma Hospital, Kobe, Japan.

Ayana Suzuki (A)

Department of Clinical Laboratory, Kuma Hospital, Kobe, Japan.

Seiji Kuma (S)

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.

Toshitetsu Hayashi (T)

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.

Takumi Kudo (T)

Department of Internal Medicine, Kuma Hospital, Kobe, Japan.

Akira Miyauchi (A)

Department of Surgery, Kuma Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH